Kyowa Kirin Co.

Kyowa Kirin Co. is a Tokyo-based global specialty pharmaceutical company and corporate strategic investor backing later-stage U.S. life sciences companies. Its strategic focus aligns with biotechnology and pharmaceuticals, including antibody technologies, hematopoietic stem cell gene therapy, bone and mineral diseases, hematologic malignancies, and rare diseases. Founders developing therapeutic platforms or cell- and gene-therapy approaches with pharma partnership relevance are the clearest fit.